Update
GSK taps Lonza for bio plant knowledge; sells R&D site to Galapagos
GSK will work with Lonza on the development of a UK biomanufacturing plant as part of a new MAb manufacturing contract announced today.
Archives for September 7, 2010
Actavis looks to enter biosimilars through acquisition
Actavis is looking to enter the biosimilars sector through the proposed acquisition of a stake in Biopartners.
ForteBio unleash Protein G biosensor for Ab drug discovery on Octet instrumentation
The life sciences company, ForteBio, has launched its Dip and Read Protein G biosensor, designed for the fast-track analysis of specific biomolecular interactions of various types of the antibody molecule, mammalian immunoglobulin.
PPD forms North American Ph I network; looks globally
PPD has set up a North American Phase I clinical trials network to increase access to patients across a broader range of disease areas.
Bristol-Myers Squibb sign $885m deal to buy ZymoGenetics
Global biopharmaceutical company, Bristol-Myers Squibb will buy ZymoGenetics for $885m to become owner of a hepatitis C drug the companies are jointly developing.
Sanofi discontinuing old insulin pens in UK
Sanofi-Aventis is discontinuing use of old insulin pen devices in the UK in response to NPSA guidance.